Yesterday, Nov. 30, 2015, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $97.50 to $4,584,763.71.

Highlighted Stocks Traded by Insiders:

Neenah Paper (NP) - FREE Research Report

Erwin Sean T, who is Director at Neenah Paper, sold 6,000 shares at $65.30 on Nov. 30, 2015. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 6,000-share transaction.

The shares most recently traded at $65.86, up $0.56, or 0.85% since the insider transaction. Historical insider transactions for Neenah Paper go as follows:

  • 4-Week # shares sold: 7,400
  • 12-Week # shares sold: 12,400
  • 24-Week # shares sold: 17,400

The average volume for Neenah Paper has been 83,100 shares per day over the past 30 days. Neenah Paper has a market cap of $1.1 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 10.29% year-to-date as of the close of trading on Monday.

Neenah Paper, Inc. produces and sells technical products and fine papers worldwide. The stock currently has a dividend yield of 1.79%. The company has a P/E ratio of 15.5. Currently, there are no analysts who rate Neenah Paper a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NP - FREE

TheStreet Quant Ratings rates Neenah Paper as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Neenah Paper Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Salesforce.com (CRM) - FREE Research Report

Benioff Marc, who is Chairman of the Board & CEO at Salesforce.com, sold 37,500 shares at $80.06 on Nov. 30, 2015. Following this transaction, the Chairman of the Board & CEO owned 37.2 million shares meaning that the stake was reduced by 0.1% with the 37,500-share transaction.

The shares most recently traded at $80.37, up $0.31, or 0.39% since the insider transaction. Historical insider transactions for Salesforce.com go as follows:

  • 4-Week # shares sold: 176,000
  • 12-Week # shares sold: 451,972
  • 24-Week # shares sold: 460,021

The average volume for Salesforce.com has been 3.7 million shares per day over the past 30 days. Salesforce.com has a market cap of $53.1 billion and is part of the technology sector and computer software & services industry. Shares are up 34.36% year-to-date as of the close of trading on Monday.

salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. Currently, there are 27 analysts who rate Salesforce.com a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRM - FREE

TheStreet Quant Ratings rates Salesforce.com as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and weak operating cash flow. Get the full Salesforce.com Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

National Healthcare (NHC) - FREE Research Report

Abernathy James Paul, who is Director at National Healthcare, sold 1,000 shares at $67.00 on Nov. 30, 2015. Following this transaction, the Director owned 20,816 shares meaning that the stake was reduced by 4.58% with the 1,000-share transaction.

The shares most recently traded at $68.95, up $1.95, or 2.83% since the insider transaction. Historical insider transactions for National Healthcare go as follows:

  • 4-Week # shares sold: 3,300
  • 12-Week # shares sold: 3,300
  • 24-Week # shares sold: 3,300

The average volume for National Healthcare has been 19,800 shares per day over the past 30 days. National Healthcare has a market cap of $998.9 million and is part of the health care sector and health services industry. Shares are up 9.96% year-to-date as of the close of trading on Monday.

National HealthCare Corporation operates, manages, or provides services to skilled nursing facilities and associated assisted living centers, retirement centers, and home health care programs. The stock currently has a dividend yield of 2.39%. The company has a P/E ratio of 21.6. Currently, there are no analysts who rate National Healthcare a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NHC - FREE

TheStreet Quant Ratings rates National Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full National Healthcare Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.